According to Enanta Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 21,088,000. At the end of 2023 the company had 21,088,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 21.08 M | 1.31% |
2022 | 20.81 M | 2.1% |
2021 | 20.38 M | 1.47% |
2020 | 20.09 M | 1.73% |
2019 | 19.75 M | 1.67% |
2018 | 19.42 M | 1.55% |
2017 | 19.13 M | 0.48% |
2016 | 19.03 M | 1.4% |
2015 | 18.77 M | 0.93% |
2014 | 18.6 M | 3.64% |
2013 | 17.94 M | 1449.97% |
2012 | 1.15 M | -90.96% |
2011 | 12.81 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 11,315.02% | ๐บ๐ธ USA |
Novartis NVS | 2,062,000,000 | 9,678.07% | ๐จ๐ญ Switzerland |
AbbVie ABBV | 1,765,940,733 | 8,274.15% | ๐บ๐ธ USA |
Vertex Pharmaceuticals VRTX | 258,000,000 | 1,123.44% | ๐บ๐ธ USA |
Merck MRK | 2,554,166,667 | 12,011.94% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | 2,057,000,000 | 9,654.36% | ๐บ๐ธ USA |